News and press releases
Gubra is sponsor of BIKE TO WORK
09 March 2020 - It’s official! Gubra is sponsor of this year’s Danish bike campaign BIKE TO WORK (VI CYKLER TIL ARBEJDE).
Co-financed industrial PhD scholarship from DDA
05 March 2020 - Congratulations to Gubra and PhD student Mathias Bonde Møllerhøj (MSc). We just received a co-financed industrial PhD scholarship from the Danish Diabetes Academy.
Gubra wins prestigious award
30 October 2019 - Gubra ApS is the winner of EY Entrepreneur Of The Year in the Zealand region.
Gubra announces the nomination of a co-invented clinical candidate from first obesity collaboration with Boehringer Ingelheim
28 June 2019 - Boehringer Ingelheim and Gubra announce the nomination of a clinical candidate for the development of novel peptide compounds to treat obesity.
Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists
29 May 2019 - Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat obesity.
JDRF and Gubra join forces to develop a new glucose responsive insulin for diabetes
18 June 2018 - JDRF and Gubra today announced a partnership to develop a glucose-responsive insulin (GRI) as a treatment for people with insulin-requiring diabetes, such as type 1 diabetes (T1D).